This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Insulet's request for provisional measures in patent dispute with Menarini dismissed by UPC

( November 22, 2024, 12:39 GMT | Official Statement) -- MLex Summary: The Unified Patent Court's Milan Local Division dismissed Insulet Corporation's application for provisional measures against Menarini Diagnostics in a dispute over European patent 4,201,327 concerning the Omnipod 5 insulin pump. Medical devices company Insulet alleged infringement of its patent by pharmaceutical company Menarini, but the court found that Insulet didn't sufficiently demonstrate the certainty of its patent validity. Insulet was ordered to pay 117,465 euros as an interim cost award, the court said.The document is attached. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents